BAUDAX BIO

no shorts are coming in this site. The stock is too small for anyone to waste their time. The trade volume is basically zero like the potential of this stock.
Once a day nsaid. It’s a gimmick.
In a year the lack of sales will reflect that
 










































Even with Premier, Vizient, and a permanent J Code, this is going nowhere fast. Greg keeps asking us to update these freakin' spreadsheets and all I do is rearrange the words from last week. This is way slower than he promised JH and GH but he wouldn't listen.
 




































Launching a drug in this environment ? How will hiring and training go? When does Offirmev go generic? How have the last two IV NSAID launches into this market fared? Answer these questions and you'll know why nobody with a decent job is going to Baudax.


You must not have a very good job if you spend your free time trollimg baudax boards